/ EN
About
About Repu
REPU
REPU

Founded in 2015 by Dr. Ding Lieming, an innovative medicine leader and State Specially Recruited Expert, Repu Technology is a high-tech life health company. Combining precision medicine and AI big data, Repu Technology is the first in China to support innovator drug approvals.

We collaborate closely with renowned pharmaceutical companies, employing AI for drug design and R&D, enhancing research efficiency, and investigating drug efficacy and resistance mechanisms. Simultaneously, we partner with clinical and research institutions to expedite new drug target discovery and early screening and diagnosis tech clinical transformation.

Our mission is to make precision healthcare accessible to everyone. We are committed to leveraging our vast clinical data resources to serve clinical needs, drive clinical translation, and act as a bridge between clinical treatment and new drug development.

Culture
Our Mission
Our Mission
Make Precision Healthcare Accessible to Everyone
Our Vision
Our Vision
Embrace the Role of Pioneers in Digital Precision Healthcare
Our Business Philosophy
Our Business Philosophy
R-Reliable
E-Efficient
P-Precise
U-Unique
Our Values
Our Values
Responsibility,Focus,Innovation,Determination,
Humanity,Synergy
Culture
Our Mission
Make Precision Healthcare Accessible to Everyone
Our Vision
Embrace the Role of Pioneers in Digital Precision Healthcare
Our Business Philosophy
R-Reliable
E-Efficient
P-Precise
U-Unique
Our Values
Responsibility,Focus,Innovation,Determination,
Humanity,Synergy
Credential
Repu Technology has consistently excelled in inter-laboratory quality assessments conducted by renowned domestic and international organizations, including CAP and NCCL. This reaffirms RepuGene's strong technical capabilities, meticulous operational procedures, and superior product design in the field of tumor gene testing. It also signifies Repugene Medical Testing Laboratory's inclusion among top-tier international medical testing facilities, with recognized standards of quality management, technical proficiency, and precision in biological data analysis.
Leadership
Dr. Ding Lieming
Dr. Ding Lieming
Founder and Chairman
Ms. Lou Shengqiong
Ms. Lou Shengqiong
Founder and CEO
Mr. Zheng Xiang
Mr. Zheng Xiang
Director of Production
Dr. Zhou Yan
Dr. Zhou Yan
Director of Strategic Development
Dr. Wang Yang
Dr. Wang Yang
Director of R&D
Dr. Meng Yiran
Dr. Meng Yiran
R&D Scientist
Dr. Zhang Mingming
Dr. Zhang Mingming
Director of Digital Engineering
Ms. Guo Lixia
Ms. Guo Lixia
Director of Marketing
Dr. Jia Lei
Dr. Jia Lei
Manager of Clinical Bioinformatics
Dr. Song Ruilin
Dr. Song Ruilin
Expert Committee Members
Mr. Wan Jiang
Mr. Wan Jiang
Expert Committee Members
Prof. Sun Wenyong
Prof. Sun Wenyong
Expert Committee Members
Prof. Shen Yiping
Prof. Shen Yiping
Expert Committee Members
Platform
Repu Technology has established a diversified hardware platform, which includes sequencing platforms equipped with Illumina Nova6000, X Ten, HiSeq4000, and MGISeq-2000, MGISeq-200, and other leading sequencers. These platforms offer robust sequencing throughput and flexible sequencing cycles. Our single-cell spatial omics platform is equipped with 10X Genomics Chromium Controller, Chromium X, Visium CytAssist, and related facilities. We were one of the first companies in the East China region to introduce a complete set of 10X single-cell instruments.
Partners
Repu Technology has established collaborations with domestic healthcare and educational institutions in China. Their research spans joint drug studies, tumor staging mechanisms, comparative genomics of patients at different stages, and drug efficacy. They've also partnered with pharmaceutical companies, notably Betta Pharmaceuticals, for tumor biomarker selection, clinical trials, efficacy monitoring, and companion diagnostics. Additionally, they've collaborated with Wenzhou Medical University to establish the "Wenzhou Medical University Institute of Pharmacogenomics Research" ,and have a strategic partnership with the Zhejiang Provincial Lung Cancer Diagnosis and Treatment.
TOP